Clinical study of topical application of Ku-Gan cream in the treatment of mild to moderate atopic dermatitis
- Conditions
- Atopic Dermatitis
- Registration Number
- ITMCTR2024000196
- Lead Sponsor
- Shanghai Skin Disease Hospital, Institute of Dermatology, School of Medicine, Tongji University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.It meets the above diagnostic criteria for atopic dermatitis;
2.Age =18 years and =65 years, gender is not limited;
3.Investigator's global assessment (IGA) score of 2~3 or Eczema area and severity index (EASI) score of 1~21, diagnosed as mild to moderate AD patients;
4.Those who understood, agreed to participate in this study and signed the informed consent form.
1. Other active skin diseases that may interfere with the assessment of the condition;
2. Patients have been systematically treated with investigational drugs, biologics and immunosuppressive agents within 1 month;
3. In a period of severe uncontrollable acute or chronic local or systemic infection;
4. Patients with severe systemic diseases; or patients whose clinical test indicators fall into one of the following categories: increased alanine aminotransferase or glutamine aminotransferase > 1.5 times the upper limit of normal; increased creatinine > 1.5 times the upper limit of normal; any of the major indicators of routine blood tests (white blood cell count, red blood cell count, haemoglobin volume, platelet count) is below the lower limit of normal; or other laboratory test abnormalities of the investigator Patients judged to be unsuitable for participation in this trial;
5. Patients with a history of malignancy and patients with primary or secondary immunodeficiency and hypersensitivity, or those with a family history of tumours;
6. Who have undergone major surgery within 8 weeks or will require such surgery during the study;
7. Women who are pregnant or breastfeeding;
8. Persons with a history of alcohol, drug or substance abuse;
9. Persons with a history or family history of severe mental illness;
10. Persons who, in the opinion of the investigator, are not suitable for participation in this study for other reasons.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method